Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
128
days
Patient preferences for sexual health counseling across the Gynecologic Cancer Care Continuum: the sexual health integration in treatment of gynecological oncology (SHIFT-GO Study)
Authors
Krzysztof Nowosielski; Joanna Kacperczyk-Bartnik; Magdalena BizońShow moreShow less
Affiliations
Medical University of Silesia, University Clinical Center, Department of Gynecology, Obstetrics and Gynecological Oncology, Katowice, Poland; Medical University of Warsaw, 2nd Department of Obstetrics and Gynecology, Warsaw, Poland; Maria Skłodowska-Curie National Research Institute of Oncology, Gynecologic Oncology Department, Warsaw, Poland; LUX MED Oncology Hospital, Department of Gynecological Oncology, Warsaw, Poland; Center of Oncology, Department of Gynecological Oncology, Bielsko-Biala, PolandShow moreShow less
95
days
Intermittent olaparib with neoadjuvant platinum-based chemotherapy in BRCA-mutated un-resectable ovarian cancer: the NUVOLA trial
Authors
Vanda Salutari; Claudia Marchetti; Elena Giudice; Camilla Nero; Diana Giannarelli; Viola Ghizzoni; Sara Lardino; Carolina Maria Sassu; Barbara Costantini; Giulia Ponti; Gian Franco Zannoni; Giovanni Scambia; Anna FagottiShow moreShow less
Affiliations
Fondazione Policlinico Universitario A. Gemelli IRCCS, Department of Woman, Child and Public Health, Rome, Italy; Università Cattolica del Sacro Cuore, Institute of Obstetrics and Gynecology, Rome, ItalyShow moreShow less
84
days
Differences in first-line chemosensitivity assessed by ELIMination rate constant K in advanced serous ovarian cancer: evidence from Western and Japanese Trials in a Gynecologic Cancer InterGroup meta-analysis
Authors
Pauline Corbaux; Benoit You; Iain McNeish; Stephen Welch; Anna V. Tinker; Mansoor R. Mirza; Kristina Lindemann; Tatsuo Kagimura; Isabelle L. Ray-Coquard; Fabien Subtil; Julien Péron; Karen Carty; Caroline Kelly; Olivier Colomban; Eleni Karamouza; Adrian Cook; Xavier Paoletti; Rosalind M. Glasspool; Nozomu YanaiharaShow moreShow less
Affiliations
Claude Bernard University Lyon 1, Faculty of Medicine Lyon-Sud, Centre pour l'lnnovation en Cancérologie de Lyon (CICLY), Lyon, France; GINECO, CHU de Saint-Etienne, Institut de Cancérologie et d’Hématologie Universitaire de Saint-Etienne, Medical Oncology, Saint-Etienne, France; GINEGEPS, GINECO, Centre Hospitalier Lyon-Sud, CITOHL, Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL), Medical Oncology, Lyon, France; Imperial College London, Department of Surgery and Cancer, London, United Kingdom; London Health Sciences Centre, London, ON, Canada; BC Cancer – Vancouver, Vancouver, BC, Canada; Nordic Society of Gynecological Oncology, Copenhagen, Denmark; Copenhagen University Hospital, Rigshospitalet, Department of Oncology, Copenhagen, Denmark; Norwegian Radium Hospital, Oslo, Norway; Translational Research Center for Medical Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Japan; Inserm U1290 Claude Bernard University Lyon 1 GINECO, Centre Léon Bérard, Lyon, France; Hospices Civils de Lyon, Service de Biostatistique, Lyon, France; Université Claude Bernard Lyon 1, LBBE, UMR 5558, CNRS, VAS, Villeurbanne, France; University of Glasgow, Institute of Cancer Sciences, Glasgow Oncology Clinical Trials Unit, Glasgow, United Kingdom; Université Paris-Saclay, Office of Biostatistics and Epidemiology, Institut Gustave Roussy, Villejuif, France; Inserm, Université Paris-Saclay, CESP U1018, Oncostat, labeled Ligue Contre le Cancer, Villejuif, France; MRC Clinical Trials Unit at UCL, London, United Kingdom; Institut Curie, St Cloud, France; Beatson West of Scotland Cancer Centre, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom; University of Glasgow, School of Cancer Sciences, Glasgow, United Kingdom; The Jikei University School of Medicine, Tokyo, JapanShow moreShow less
109
days
Quality of life and patient-reported outcomes after non-surgical management of early-stage endometrial cancer and endometrial hyperplasia with atypia: a long-term follow-up of the feMMe phase II randomized clinical trial
Authors
Katharina Steger; Eva Baxter; Ruqaiya Al Ramadhani; Monika Janda; Andreas ObermairShow moreShow less
Affiliations
The University of Queensland, Queensland Centre for Gynaecological Cancer Research, Brisbane, QLD, Australia; Medical University of Innsbruck, Department of Obstetrics and Gynecology, Innsbruck, Austria; The University of Queensland, Faculty of Health, Medicine and Behavioral Sciences, Centre for Health Services Research, Brisbane, QLD, AustraliaShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days